日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia.

药理学抑制 ENaC 或 NCX 可减轻高钠血症加剧的肝脏缺血再灌注损伤

期刊:Journal of Zhejiang University-Science B
影响因子:4.9
doi:10.1631/jzus.B2300825
Chen Yabin, Li Hao, Wen Peihao, Zhang Jiakai, Wang Zhihui, Cao Shengli, Guo Wenzhi
信号转导
发表日期：2025
文献求助 收藏

Clinical significance and gene prediction of a novel classification system based on tacrolimus concentration-to-dose ratio in the early post-liver transplant period

基于他克莫司浓度剂量比的新型分类系统在肝移植早期临床意义及基因预测

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1614753
Fan, Junwei; Wen, Peihao; Yuan, Liyun; Xia, Yan; Hu, Shijie; Zhang, Xiaoqing; Peng, Zhihai
发表日期：2025
文献求助 收藏

Erratum: HMOX1+ macrophages determine immunosuppressive microenvironment and immunotherapy efficacy in hepatocellular carcinoma

更正：HMOX1+巨噬细胞决定肝细胞癌的免疫抑制微环境和免疫治疗疗效

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000861
Du, Yabing; Xu, Wenxin; Liu, Zhenkun; Wen, Peihao; Song, Ruifeng; Hao, Weiwei; Liu, Yating; Zhao, Xinlei; Gu, Meiying; Weng, Jialei; He, Wei
巨噬细胞
肿瘤
肿瘤免疫
巨噬细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

HMOX1+ macrophages determine immunosuppressive microenvironment and immunotherapy efficacy in hepatocellular carcinoma.

HMOX1+巨噬细胞决定肝细胞癌的免疫抑制微环境和免疫疗法疗效。

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000815
Du Yabing, Xu Wenxin, Liu Zhenkun, Wen Peihao, Song Ruifeng, Hao Weiwei, Liu Yating, Zhao Xinlei, Gu Meiying, Weng Jialei, He Wei
巨噬细胞
肿瘤
肿瘤免疫
巨噬细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

BRD4 interacting genes as prognostic biomarkers in hepatocellular carcinoma for optimized treatment strategies

BRD4相互作用基因作为肝细胞癌预后生物标志物，可用于优化治疗策略

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-89614-9
Zhang, Huapeng; Yu, Jie; Zhang, Feng; Liu, Qi; Pan, Jie; Wen, Peihao; Lu, Danyang; Liu, Rong; Wang, Tong; Wang, Senyan
BRD4
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Multi-omics and machine learning refine HCC molecular subtypes and prognosis based on liquid-liquid phase separation related genes

基于液-液相分离相关基因的多组学和机器学习方法可改进肝细胞癌分子亚型和预后判断

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-28551-z
Li, Minghao; Liu, Qi; Gao, Jie; Liu, Lei; Tao, Ruolin; Wang, Zhihui; Shi, Xiaoyi; Wen, Peihao; Zhang, Yi; Zhang, Shuijun
细胞生物学
肿瘤
肿瘤免疫
相分离
发表日期：2025
文献求助 收藏

Impact of varied immunosuppressive agents and post-transplant diabetes mellitus on prognosis among diverse transplant recipients (experimental studies)

不同免疫抑制剂和移植后糖尿病对不同移植受者预后的影响（实验研究）

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000001135
Liu, Yuan; Zheng, Jinxin; He, Qining; Zhang, Haijiao; Wen, Peizhen; Wen, Peihao; Ge, Jifu; Yang, Yang; Zhang, Tao; Wang, Rangrang
代谢
糖尿病
免疫/内分泌
发表日期：2024
文献求助 收藏

Effects of donors' and recipients' preoperative serum sodium on the prognosis of liver transplantation

供体和受体术前血清钠水平对肝移植预后的影响

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-71218-4
Chen, Yabin; Li, Hao; Zhang, Menggang; Wu, Zeyu; Fang, Haoran; Wen, Peihao; Zhang, Jiakai; Guo, Wenzhi
信号转导
发表日期：2024
文献求助 收藏

Genotype-guided model significantly improves accuracy of tacrolimus initial dosing after liver transplantation

基因型指导模型显著提高了肝移植后他克莫司初始给药的准确性

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2022.101752
Shi, Baojie; Liu, Yuan; Liu, Dehua; Yuan, Liyun; Guo, Wenzhi; Wen, Peihao; Su, Zhaojie; Wang, Jie; Xu, Shiquan; Xia, Junjie; An, Wenbin; Wang, Rui; Wen, Peizhen; Xing, Tonghai; Zhang, Jinyan; Gu, Haitao; Wang, Zhaowen; Zhong, Lin; Fan, Junwei; Li, Hao; Zhang, Weituo; Peng, Zhihai
发表日期：2023
文献求助 收藏

Dysfunctional epigenetic protein-coding gene-related signature is associated with the prognosis of pancreatic cancer based on histone modification and transcriptome analysis

基于组蛋白修饰和转录组分析，功能异常的表观遗传蛋白编码基因相关特征与胰腺癌的预后相关。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-27316-2
Yu, Xiao; Wang, Yun; Shi, Xiaoyi; Wang, Zhihui; Wen, Peihao; He, Yuting; Guo, Wenzhi
肿瘤
表观遗传
肿瘤免疫
组蛋白修饰
胰腺癌
发表日期：2023
文献求助 收藏